Larvol Delta - A-Study-to-Assess-the-Safety-Pharmacokinetics-and-Efficacy-of-ABI6250-in-Participants-With-Chronic-Hepatitis-D-Virus-Infection

ABI-6250 - Assembly Biosci, Gilead

http://clinicaltrials.gov/ct2/show/NCT07762027

Aug 14, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next